Stocks
Deciphera Pharmaceuticals (DCPH) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -768.8% | -627.7% | -312.1% | -136.3% | -127.9% | -116.6% | ||
| Changes by years, y/y, % | +141pp | +316pp | +176pp | +8pp | -36.1% | ||||
Deciphera Pharmaceuticals. EBITDA margin, %
Deciphera Pharmaceuticals. EBITDA margin, changes, pp
Deciphera Pharmaceuticals (DCPH) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -159.2% | -136.3% | -124.0% | -105.2% | -105.0% | -116.6% | |
| Changes by years, y/y, % | +1pp | -4pp | -1pp | +25pp | +54pp | |||
| Changes by quarters, q/q, % | -29pp | +23pp | +12pp | +19pp | +0pp | |||
